What is Phaffia Yeast?
Phaffia yeast (Xanthophyllomyces dendrorhous, formerly classified as Phaffia rhodozyma) is a naturally occurring microorganism belonging to the family of basidiomycete yeasts. This yeast is notable for its ability to synthesize and accumulate astaxanthin, a red-orange carotenoid pigment, within its cells. The yeast itself serves as the source of color in food applications, rather than extracting and isolating the pigment separately. CAS Number 977165-85-7 identifies this specific substance in regulatory databases.
Common Uses
Phaffia yeast is primarily used as a natural food colorant in aquaculture feed, particularly for farmed salmon and trout, where it imparts the characteristic pink coloration to fish flesh. This application has gained significant interest as an alternative to synthetic astaxanthin or astaxanthin derived from other sources. Beyond aquaculture, the yeast shows potential for use in other food and beverage applications where red or pink coloring is desired, though commercial adoption in non-aquaculture products remains limited in many markets.
The use of whole yeast cells as a colorant represents a different regulatory approach compared to isolated pigments, as it constitutes a food ingredient derived from a microorganism rather than a chemical additive.
Safety Assessment
Phaffia yeast has generated no adverse event reports in FDA databases and has not been subject to any FDA recalls. The safety profile appears favorable based on available surveillance data. The yeast is derived from a non-pathogenic microorganism, and astaxanthin itself is recognized as a safe carotenoid widely present in marine organisms.
It is important to note that while Phaffia yeast has not received GRAS (Generally Recognized As Safe) status from the FDA, this does not necessarily indicate a safety concern. Rather, it reflects the regulatory classification and approval pathway chosen for this substance. Different regulatory jurisdictions have varying approval statuses; the European Food Safety Authority (EFSA) and other regulatory bodies have evaluated this ingredient under different frameworks.
The absence of adverse events and recalls suggests that where the product has been used, no significant safety issues have emerged in post-market surveillance. However, the limited use history compared to synthetic colorants means the total exposed population remains relatively small.
Regulatory Status
Phaffia yeast does not hold FDA GRAS status in the United States, which means it is not classified as generally recognized as safe for use in food without specific approval. This may limit its use in certain food categories under U.S. regulatory framework, depending on how it is classified (as a food ingredient, food additive, or novel food).
Regulatory approval varies by jurisdiction. Some countries and regions may permit its use under different regulatory pathways, such as novel food approvals or ingredient notifications. Manufacturers and importers should verify current regulatory status in their specific market before commercial use.
The microbial origin of Phaffia yeast may subject it to additional scrutiny regarding fermentation practices, contamination controls, and processing validation compared to chemical colorants.
Key Studies
Scientific literature on Phaffia yeast primarily focuses on its use in aquaculture applications and astaxanthin production efficiency. Research has demonstrated that the yeast effectively accumulates astaxanthin under specific fermentation conditions and that inclusion in aquaculture feed produces the desired pigmentation in farmed fish.
Studies on astaxanthin from various sources, including Phaffia yeast, have examined bioavailability and antioxidant properties. The toxicological profile of astaxanthin itself has been extensively studied and generally considered safe at dietary levels.
Additional research continues on optimizing fermentation yield, cost-effectiveness compared to alternatives, and potential expansion into other food applications. Current literature suggests safety concerns are minimal, though long-term consumption studies in human populations remain limited.